Well I am a true long with 300,000 shares and I am not gonna hit the panic sell button as I've been in this situation many times over the years but I can admit I am quite concerned. Oh btw I do enjoy Shawn's posts and do not view them as bashing, just maybe a frustrated long like myself. I am expecting Q1 sales to be a minimum of 2.7 million, if it's any lower than that I think we're in trouble. Hopefully as I indicated in my previous post we may see the perfect storm of good news of quarterly sales increases and an FDA approval of Fluticare, EU deals. When I take a step back and look at the situation logically it all makes sense about where we are now. A slight miss in revenue for 2016, albeit not much at all and even a win considering the decrease in advertising in December 2016, an officer leaving the company, issuance of shares to Novalere, a capital raise at seemingly less than favorable terms. Yet all of that has a logical explanation. I will remain cautiously optimistic, what do you think Shawn? GLTA